Up to one in every five adults has sleep-disordered breathing (SDB).
An expanding body of scientific evidence has established the potentially adverse effects of untreated sleep apnoea on patients.
Through its strong partnership with the global medical community, ResMed is committed to:
- Increasing awareness of SDB, its effects and treatment
- Supporting ongoing research on SDB with other health risks
- Finding effective clinical solutions to improve the health and lives of SDB patients
Consult our research and clinical papers on sleep apnoea below.
Sleep-disordered breathing and positive airway pressure
Read more research on the topics of sleep-disordered breathing (SDB) and positive airway pressure (PAP).
Diabetes and sleep apnoea
Explore research about diabetes in relation to sleep and respiratory care.
Obesity and sleep apnoea
Read about obesity research in relation to sleep-disordered breathing and respiratory care.
Sleep-related traffic and occupational accidents
Read about research on traffic accidents in relation to sleep and respiratory care.
Screening for OSA
Find out more about the research validating ResMed’s screening technologies.
Sleep therapy compliance
Read about research on compliance in relation to positive airway pressure therapy.
Explore the research around ResMed’s AutoSet algorithm and how it works.